# A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension

> **NCT02791438** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 27 (actual)

## Conditions studied

- Pediatric Hypertension

## Interventions

- **DRUG:** Azilsartan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02791438
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-18
- **Primary completion:** 2019-06-04
- **Final completion:** 2019-06-04
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2020-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02791438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02791438, "A Phase 3 Long-term Study of TAK-536 in Pediatric Patients 6 to Less Than 16 Years With Hypertension". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT02791438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*